Back to search
🇺🇸

United States · US · US:24979-250_1ae3fb8f-0340-45e5-9f71-fe284c0a6037

Naprelan

Orange BookUNIISPLATC G02CC02

Last synced from FDA National Drug Code directory (United States) on

Identification

ManufacturerUpsher-Smith Laboratories, LLC
CountryUS (United States)
ATC codeG02CC02
Dispensing
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026

Packs · 1

  • ndc11
    2497925068
    75 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-250-68)

Annotations

UNII (FDA Substance ID)
9TN87S3A3C
NAPROXEN SODIUM
RxCUI 142442
Orange Book
N020353
ABABAB
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
  "unii": {
    "unii": "9TN87S3A3C",
    "rxcui": "142442",
    "inchikey": "CDBRNDSHEYLDJV-FVGYRXGTSA-M",
    "display_name": "NAPROXEN SODIUM",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "spl_meta": {
    "b8a51c9a-488e-4377-a041-436f6a2f8893": {
      "match": "brand_token",
      "title": "NAPRELAN (NAPROXEN SODIUM) TABLET, FILM COATED, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, LLC]",
      "spl_version": "2",
      "published_date": "2026-01-09"
    }
  },
  "productid": "24979-250_1ae3fb8f-0340-45e5-9f71-fe284c0a6037",
  "productndc": "24979-250",
  "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
  "orange_book": {
    "appl_no": "020353",
    "products": [
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "EQ 375MG BASE",
        "product_no": "001",
        "approval_date": "Jan 5, 1996"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "EQ 500MG BASE",
        "product_no": "002",
        "approval_date": "Jan 5, 1996"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": "AB",
        "strength": "EQ 750MG BASE",
        "product_no": "003",
        "approval_date": "Jan 5, 1996"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "NAPROXEN SODIUM",
  "proprietary_name": "Naprelan",
  "active_ingred_unit": "mg/1",
  "application_number": "NDA020353",
  "marketing_category": "NDA",
  "nonproprietary_name": "Naproxen Sodium",
  "start_marketing_date": "20251231",
  "active_numerator_strength": "500"
}

Related drugs

Other records sharing ATC code G02CC02.

Access this data programmatically

Query Naprelan and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.